Mumbai-based medtech startup Bioscan Research has raised $1 million in a seed funding round led by Unicorn India Ventures.
The proceeds will be used for market expansion, securing additional regulatory approvals, upgrading its products and creating new intellectual property.
Founded in 2017 by Anupam Lavania and Shilpa Malik, Bioscan Research develops non-invasive medical devices for the early detection of brain injuries. Its flagship product, CEREBO, uses near-infrared spectroscopy (NIRS) and machine learning to detect intracranial injuries, enabling early diagnosis of traumatic brain injuries even before visible symptoms appear.
According to the company, its technology is designed to help healthcare providers identify brain injuries during the critical treatment window and improve patient outcomes.
Bioscan Research said it recorded 5x growth over the past 12 months. It aims to grow threefold over the next year by expanding its presence in India and overseas markets.
Founded in 2016, Unicorn India Ventures is an early-stage venture capital firm focused on deeptech startups across sectors including semiconductors, spacetech, AI infrastructure and medical diagnostics.